Healthy volunteer study aims to sharpen future diagnostic tests
NCT ID NCT05160337
First seen Jun 27, 2026 · Last updated Jun 27, 2026
Summary
This study looks at how stable certain biomarkers (like RNA and proteins) are in healthy volunteers. Researchers want to see if things like age, gender, or eating affect these markers. The goal is to make future diagnostic tests more reliable. The study involves 60 healthy adults aged 18 to 85.
What this could mean
Our plain-language read of the trial. This is informational only — not medical advice or a prediction.
- Active substance
- Biomarker based IVD tests
- What this could lead to
- If successful, this could help create more reliable diagnostic tests for various diseases by understanding how biomarkers behave in healthy people.
- What could go wrong
- This is a small, early-stage study in healthy volunteers only, so results may not apply to people with diseases. It does not test any treatment.
This is an AI summary of the original study and may miss details. Read our disclaimer.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for HEALTHY are added.
By submitting, you agree to our Terms of use
As listed by the trial registrant
The condition terms exactly as the trial's registrant entered them.
Contacts and locations
Show contact details
Enter your email to view the contact information for this study.
By submitting, you agree to our Terms of use
Study contacts
-
Contact
Email: •••••@•••••
-
Contact
Email: •••••@•••••
Locations
-
Firalis Clinical Investigation Center
RECRUITINGHuningue, 68330, France
More trials for these conditions
Other studies related to the condition(s) this trial covers.
- Could a new oral drug change future treatments? early safety trial begins
- Can brain scans unlock the secret to hearing in crowded rooms?
- Can a Light-Guided device make arterial sticks easier?
- Water workouts could be the key to back pain relief
- Could everyday disinfectants be harming us? a new study investigates
- Can a new drug keep the Heart's beat steady? trial puts verducatib to the test